Skip to main content
Home > Week in Review > Offerings

Chronological Index of : Financial News

 Current Issue
  • Aduro Biotech amends IPO

    Aduro Biotech Inc., Berkeley, Calif. Business: Cancer Date announced: 2015-04-06 Type: IPO To be raised: Up to $80 million Shares: 5 million Price: $14-$16 Underwriters: BofA Merrill Lynch; Leerink Partners; William …

    Published on 4/13/2015
  • BiondVax Pharmaceuticals Ltd amends follow-on

    BiondVax Pharmaceuticals Ltd. (Tel Aviv:BNDX), Ness Ziona, Israel Business: Infectious Date announced: 2015-04-06 Type: Follow-on To be raised: TBD Shares: TBD Price prior: NIS0.66 Underwriter: Aegis Capital …

    Published on 4/13/2015
  • Cidara Therapeutics amends IPO

    Cidara Therapeutics Inc., San Diego, Calif. Business: Infectious Date announced: 2015-04-06 Type: IPO To be raised: Up to $64 million Shares: 4 million Price: $14-$16 Underwriters: Jefferies; Leerink Partners; Wedbush; …

    Published on 4/13/2015
  • KemPharm amends IPO

    KemPharm Inc., Coralville, Iowa Business: Neurology Date announced: 2015-04-03 Type: IPO To be raised: Up to $56 million Shares: 4 million Price: $12-$14 Underwriters: Cowen; RBC Capital Markets; Canaccord; Oppenheimer …

    Published on 4/13/2015
  • Marina Biotech Inc amends follow-on

    Marina Biotech Inc. (Pink:MRNA), Bothell, Wash. Business: Cancer, Endocrine/Metabolic Date announced: 2015-04-06 Type: Follow-on To be raised: Up to $25 million Units: 43.1 million Price prior: $0.63 Underwriters: Roth …

    Published on 4/13/2015
  • OpGen amends IPO

    OpGen Inc., Gaithersburg, Md. Business: Diagnostic, Bioinformatics, Pharmacogenetics Date announced: 2015-04-06 Type: IPO To be raised: Up to $37.5 million Shares: 3.8 million Price: $8-$10 Underwriter: Maxim Group …

    Published on 4/13/2015
  • Silence Therapeutics pl amends placing

    Silence Therapeutics plc (LSE:SLN), London, U.K. Business: Cancer, Pulmonary Date announced: 2015-04-08 Type: Placing To be raised: Up to L40 million ($59.7 million) Shares: 16.7 million Price: 240p Shares outstanding …

    Published on 4/13/2015
  • Admera Health completes venture financing

    Admera Health, South Plainfield, N.J. Business: Diagnostic Date completed: 2015-04-07 Type: Venture financing Raised: Not disclosed Investors: Prime Value Capital Management; Sungent Bioventure Note: The amount raised …

    Published on 4/13/2015
  • Alzheon completes venture financing

    Alzheon Inc., Framingham, Mass. Business: Neurology Date completed: 2015-04-08 Type: Venture financing Raised: $10 million Investors: Ally Bridge Group; new investors; existing investors

    Published on 4/13/2015
  • Antibe Therapeutics Inc completes private placement of units

    Antibe Therapeutics Inc. (TSX-V:ATE; OTCQX:ATBPF), Hamilton, Ontario Business: Inflammation, Neurology, Autoimmune Date completed: 2015-04-09 Type: Private placement of units Raised: C$464,000 ($372,499) Units: 4.6 …

    Published on 4/13/2015
  • Ark Biosciences completes venture financing

    Ark Biosciences Inc., Shanghai, China Business: Infectious Date completed: 2015-04-08 Type: Venture financing Raised: Not disclosed Investors: Qiming Venture Partners; Morningside Venture Investments; TF Capital Note: …

    Published on 4/13/2015
  • Carbylan Therapeutics Inc completes IPO

    Carbylan Therapeutics Inc. (NASDAQ:CBYL), Palo Alto, Calif. Business: Neurology Date completed: 2015-04-08 Type: IPO Raised: $65 million Shares: 13 million Price: $5 Shares after offering: 24.2 million Underwriters: …

    Published on 4/13/2015
  • Cellular Biomedicine Group Inc completes private placement

    Cellular Biomedicine Group Inc. (NASDAQ:CBMG), Palo Alto, Calif. Business: Gene/Cell therapy Date completed: 2015-04-07 Type: Private placement Raised: $19.6 million Shares: 515,789 Price: $38 Shares after offering: 11.…

    Published on 4/13/2015
  • Cerulean Pharma Inc completes follow-on

    Cerulean Pharma Inc. (NASDAQ:CERU), Cambridge, Mass. Business: Drug delivery, Cancer Date completed: 2015-04-07 Type: Follow-on Raised: $40.3 million Shares: 6.7 million Price: $6 Shares after offering: 27.1 million …

    Published on 4/13/2015
  • Dyax Corp completes follow-on

    Dyax Corp. (NASDAQ:DYAX), Burlington, Mass. Business: Inflammation, Ophthalmic Date completed: 2015-04-07 Type: Follow-on Raised: $199.8 million Shares: 7.4 million Price: $27 Shares after offering: 144.2 million …

    Published on 4/13/2015
  • Edge Therapeutics completes venture financing

    Edge Therapeutics Inc., Berkeley Heights, N.J. Business: Neurology, Drug delivery Date completed: 2015-04-09 Type: Venture financing Raised: $56 million Placement agents: Credit Suisse; Leerink Investors: Venrock; …

    Published on 4/13/2015
  • Embera completes venture financing

    Embera NeuroTherapeutics Inc., Shreveport, La. Business: Neurology Date completed: 2015-04-10 Type: Venture financing Raised: $2 million Investors: HRA Pharma; existing investors; angel investors; private investors Note…

    Published on 4/13/2015
  • MabVax Therapeutics Holdings Inc completes private placement of units

    MabVax Therapeutics Holdings Inc. (OTCQB:MBVX), San Diego, Calif. Business: Cancer Date completed: 2015-04-06 Type: Private placement of units Raised: $11.6 million Units: 15.5 million Price: $0.75 (unit) Shares after …

    Published on 4/13/2015
  • Nabriva completes venture financing

    Nabriva Therapeutics AG, Vienna, Austria Business: Infectious Date completed: 2015-04-07 Type: Venture financing Raised: $50 million Investors: Vivo Capital; OrbiMed Advisors; EcoR1 Capital; Tavistock Life Sciences; HBM…

    Published on 4/13/2015
  • Natera completes venture financing

    Natera Inc., San Carlos, Calif. Business: Diagnostic Date completed: 2015-04-06 Type: Venture financing Raised: $55.5 million Investors: Sofinnova Ventures; Capital Research and Management Co.; Franklin Templeton; …

    Published on 4/13/2015
  • NeuroNascent completes venture financing

    NeuroNascent Inc., Clarksville, Md. Business: Neurology Date completed: 2015-04-06 Type: Venture financing Raised: Not disclosed Investor: Institutional investors Note: NeuroNascent raised an undisclosed amount in a …

    Published on 4/13/2015
  • Opexa Therapeutics Inc completes rights offering

    Opexa Therapeutics Inc. (NASDAQ:OPXA), The Woodlands, Texas Business: Autoimmune, Gene/Cell therapy Date completed: 2015-04-09 Type: Rights offering Raised: $13.8 million Shares: 25.1 million Price: $0.55 (unit) Shares …

    Published on 4/13/2015
  • PhoreMost completes venture financing

    PhoreMost Ltd., Cambridge, U.K. Business: Cancer Date completed: 2015-04-07 Type: Venture financing Raised: L2.5 million ($3.7 million) Investors: Cambridge Angels; Amadeus Capital Partners; o2h Ventures; Cambridge …

    Published on 4/13/2015
  • Prothena Corp. pl completes follow-on

    Prothena Corp. plc (NASDAQ:PRTA), Dublin, Ireland Business: Antibodies, Endocrine/Metabolic, Neurology Date completed: 2015-04-08 Type: Follow-on Raised: $122.1 million Shares: 3.3 million Price: $37 Shares after …

    Published on 4/13/2015
  • Raptor Pharmaceutical Corp completes follow-on

    Raptor Pharmaceutical Corp. (NASDAQ:RPTP), Novato, Calif. Business: Neurology, Endocrine/Metabolic, Renal Date completed: 2015-04-02 Type: Follow-on Raised: $98.3 million Shares: 10.9 million Price: $9 Shares after …

    Published on 4/13/2015

< Previous   1  2  3  4  5  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993